Figure 7
Immunophenotype after cytoreduction and neonatal BMT. All mice were age-matched (200-240 days) in the experimental arms: ADA-deficient mice (no cytoreduction, n = 3; 100 cGy, n = 7; 200 cGy, n = 2; and 400 cGy, n = 1; busulfan, n = 6) after 240 days. (A) Absolute numbers of thymocytes and splenocytes. Data are means plus or minus SEM. Significant dose-response in splenocytes (P < .001). (B) Absolute numbers in each thymocyte subpopulation (CD4+, CD8+, double-positive (DP): CD4+, CD8+, double-negative (DN): CD4−, CD8−) were calculated by multiplying the total numbers of cells collected from the thymus by the percentage of cells in each subpopulation. (C) Absolute numbers in each splenocyte subpopulation (CD4+, CD8+, CD19+) were calculated by multiplying the total numbers of cells collected from the spleen by the percentage of cells in each subpopulation. Significant dose-response in CD19+ (P < .001).

Immunophenotype after cytoreduction and neonatal BMT. All mice were age-matched (200-240 days) in the experimental arms: ADA-deficient mice (no cytoreduction, n = 3; 100 cGy, n = 7; 200 cGy, n = 2; and 400 cGy, n = 1; busulfan, n = 6) after 240 days. (A) Absolute numbers of thymocytes and splenocytes. Data are means plus or minus SEM. Significant dose-response in splenocytes (P < .001). (B) Absolute numbers in each thymocyte subpopulation (CD4+, CD8+, double-positive (DP): CD4+, CD8+, double-negative (DN): CD4, CD8) were calculated by multiplying the total numbers of cells collected from the thymus by the percentage of cells in each subpopulation. (C) Absolute numbers in each splenocyte subpopulation (CD4+, CD8+, CD19+) were calculated by multiplying the total numbers of cells collected from the spleen by the percentage of cells in each subpopulation. Significant dose-response in CD19+ (P < .001).

Close Modal

or Create an Account

Close Modal
Close Modal